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Abstract
The X5 gene Is expressed specifically In pre-B cells; during B lymphocyte differentiation the
expression of the X5 gene Is turned on In pre-B cells and turned off again at the mature B cell
stage. No other cell type has yet been found to express the X5 gene. The pre-B cell-specific
expression of the X5 gene Is regulated at the level of transcription. We asked whether the region
5' of the XS gene (5'^) could explain the stage- and tissue-specific expression. The X5 promoter
lacks a TATA box and transcription Is initiated at multiple sites. In the presence of a
heterologous enhancer, 5'^ confers pre-B cell-specific expression on the reporter gene
chloramphenlcol acetyl-transferase. Deletion analysis of 5'^ defines two separaste regions,
referred to as A^ and B^. Region B^ suppresses the expression In non pre-B cells since deletion
of Bxg allows Au to promote transcription of the reporter gene In all cell types tested. In addition,
B^ acts as an enhancer on the heterologous x light chain promoter In pre-B cells but not In B
cells. Thus region A^ functions as a basal promoter In all cell types tested. Region B^, In
concert with a heterologous enhancer, acts as a suppressing region In non-pre-B cells and
therefore confers pre-B cell specificity on the expression of the X5 gene.
Introduction
In the bone marrow, pluripotent stem cells give rise to pre-B cells
that can differentiate into mature B cells. Normal pre-B cells in
bone marrow lose X5 expression at the transition from Ig /i heavy
chain expressing pre-B cells to immature surface lgM+ B cells,
while transformed pre-B and immature B cells all express the X5
gene (1 - 4). Normal and transformed mature B cells, and all other
cell types tested, do not express X5 (1). The pre-B cell-specific
expression of X5 is regulated at the level of transcription (5).
Initiation of transcription of many genes is determined by a
TATA element at —30 bp upstream of the transcription initiation
site (6,7); however, the X5 gene as well as other genes active
in pre-B cells such as Vpre.B (8), terminal deoxynucleo-
tidyltransferase (TdT) (9), mb-1 (10,11) and CD19 (12) do not
contain a TATA element. Lack of a TATA element often results
in initiation of a transcription at multiple sites, and this has also
been observed with the X5 gene (5,13).
The promoter regions of the TdT (14), mb-1 (10,11,15) and
Vpre-Bi (8) genes encode information that ensures their specific
expression pattern in cell lines. This could be due to activation
in permissive cells, to silencing in non-permissive cells or both.
For instance, the turn-off of expression of the X5 gene in later
mature stages of B cell development could involve the loss of
a transcriptional activator or the production of a transcriptional
repressor. The latter mechanism is favoured by the observation
that the expression of X5 is not detectable in hybrids between
fetal liver pre-B cells and a B cell myeloma (3). The data in this
paper support the second possibility, i.e. that the X5 gene
expression is regulated by cell-type specific suppression.
Methods
Animals
CBA/J mice were obtained from the Institute fur Biologisch-
Medizinische Forschung AG (Fullinsdorf, Switzerland).
Tissue culture conditions
Murine spleen cells in single cell suspension were depleted of
red cells and thereafter cultured in Iscove's modified Dulbecco's
modified Eagles medium supplemented with 5% FCS, antibiotics
and 5x10~5 M 2-mercaptoethanol. The spleen cell cultures
(5x10* cells/ml) were incubated in the presence of lipopoly-
saccharide (LPS, Escherichia coli 055:B5; Difco, Detroit, Ml) at
a final concentration of 50 /tg/ml. The murine pre-B cell line
230-238 (16), the murine B cell lymphomas WEHI 279 (17) and
K46R (18), and the murine T cell leukaemia EL-4 (19) were
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cultured in medium as above. The murine fibroblast line, 3T3,
was cultured in the same medium with the following.exceptions:
the 2-mercaptoethanol was omitted and the amount of FCS was
10%. All cells described above have been tested for X5 gene
expression as described (1,3) or by us and only the pre-B cell
line 230-238 was found positive.
RNA preparation and RNase protection mapping
RNA from non-transfected and transiently transfected cells was
prepared as NP40 lysates as described (20). A DNase step was
included which turned out not to be necessary.
The RNase protection mapping probe was labelled with
[a-^PJUTP according to the manufacturer (Promega, Madison,
Wl). The pGS'^-globin plasmid was made by us (see DNA
constructs). The pGS'xs-globin probe was hybridized with 20 /ig
total RNA at 37°C. The hybridizations were incubated overnight.
Next day samples were treated with RNaseA and T1. The
protected fragments were separated on a PAGE 8 M urea gel
followed by autoradiography. As molecular weight marker,
[a-^PldCTP labelled pBR322 Msp\ digested DNA (NEB,
Beverly, MA) was used.
Transfection and chtoramphenicolacetyttransferase (CAT) assay
Cells were transiently transfected using DEAE-dextran as
described (21) with the following exceptions: 2.5 x 106 cells per
transfection sample were used for all cell lines and the LPS blasts
were used at 107 cells per sample. The 3T3 cells were plated
at 0.7X106 cells in a 10 cm Petri dish the day before trans-
fection and transfected as the other cells (in the plates).
Cells were harvested 40 - 46 h after transfection. Cell extracts
or RNA were prepared, tested in CAT assay (22) as described
(21) or RNase protection mapping. The thin layer chromato-
graphy plates (CAT assay) were measured on a phosphor imager
(Molecular Dynamics, Sunnyvale, CA). The amount of CAT
activity was determined as the amount (%) of acetylated
chloramphenicol of the total amount of radioactivity in the
respective sample. The variation between duplicates within one
experiment was <10% unless stated with the exception of
activities < 1 % in which duplicates sometimes varied by 20%.
In case of CAT activities >30%, where the assay is no longer
linear, the samples were tested as 2-fold dilutions.
DNA constructs
All DNA constructs were made using conventional DNA
techniques (20). The pSV2CAT construct has been described
before (22). The transfection construct 5',-CAT-E, (1.5 kb IgL*
promoter and IgH intron, E,,, enhancer) has been described
before as L-CAT-E (21). A^-CAT-E,, described elsewhere as
x'-CAT-E (23) contains the most 3' 150 bp of the 5'x promoter.
The X5 promoters used in the transfection vectors were either
made by polymerase chain reaction (PCR) (Gene Amp) or
annealed oligonucleotides. All oligonucleotides were made such
that they contained a H/ndlll site at the 5' end (with two extra
nucleotides to protect the H/ndlll site) to make it possible to
subclone the fragments in both orientations into the unique 5'
H/ndlll site of the pUC-CAT vectors (21), i.e. pUC-CATand pUC-
CAT-E,. The CAT reporter gene contains its own ATG start
codon. As template in the PCR reactions, the plasmid 7pB12-2
containing the X5 genomic gene (13) was used. To make the
constructs 5'xs-CAT, 5'^-CAT-E, and XS'^-CAT-E, (X denotes
the 5'^ in the opposite orientation) the 725 bp X5 promoter PCR
product was first cloned in pGEM bluescript (Promega, Madison,
Wl), then excised from this (pG5\5) plasmid as a H/ndlll frag-
ment and subcloned in the respective vectors. For the
5'^-globin-E, the X5 promoter was excised as a H/ndlll frag-
ment, filled in by Kleenow and ligated in the unique Acc\ site (after
Kleenow fill in) of the OVEC-H (24) vector. The 5'^ promoter
deletion constructs with the SV40 enhancer, E&, were made by
deleting E, from the corresponding construct using SamHI and
replacing it with Esv. The following PCR 5' primers were used
for the respective deletion contructs:
5'xs;
- 2 7 2 ^ ;
TTATATGTCACAGGCTGGCCTTGA,
CAGGTGTTCAGTTGCTCTCTACGG,
TGGATATCAGTCAGGCAGAGCTGC,
AACTCCACAGATGGTGACCATGGGC,
CCTGCTGGTGGTGGAAACTAGAGA,
CTACACAGATCCACCTGCACTGGA.
The same 3' primer was used in all these constructs; TGACCC-
TCAAGTCCAAAGTCAACT. For the + 59^ and the +90^
constructs, annealed oligonucleotides were used. +59^; GGA-
GATCTACACTGCAAGTGAGGCTAGAGTTGACTTTGGACTTG-
AGGGTCAand +90x5; GACTTTGGACTTGAGGGTCA.
Region B^ of the X5 promoter was made by PCR using the
same 5' primer as the 5'^ and as 3' primer; ACAAGCTTCTC-
TCCCAAAGGACTACCCGGTTG. The PCR product was cloned
in both orientations into the unique H/ndlll site 5' of the A,
promoter of the A.-CAT-E, vector to make (XJB^-A^-CAT-E,,. X
denotes B^ in the opposite orientation. (XJB^-A^-CAT was
made by excising E/i from (^B^-A^CAT-E,,. All X5 promoter
constructs were confirmed by sequencing (Sequenase).
pG5\5-globin was made by excising the 440 bp
Pvull-SamHI fragment from 5'xs-globin-E, and cloned into
pGEM bluescript (Promega). This fragment corresponds to
position -140 in 5'^, polylinker and 200 bp of the rabbit /S-
globin gene.
Results
Multiple initiation sites for transcription of the X5 gene in pre-B cells
Kudo et al. have observed two major transcription start sites in
the X5 gene detectable by primer extension techniques (13) and
an additional major start site detectable by S1 nuctease mapping
(5). We have confirmed and extended these results with the
RNase protection technique and have found several additional
minor transcription start sites as shown in Fig. 1 (A). In the 230-238
pre-B cell line (Fig. 1 A, lane I), transcription of the endogenous
X5 gene was initiated at three major ( # 3 - #5) and four minor
sites (#1 , #2, #6 and #7) as detected by the pGS'^-globin
probe (Fig. 1B). The same start sites were also found using RNA
from another pre-B cell line, NFS-5 (data not shown). Identical
results were obtained with a similar probe lacking the globin
region (data not shown). The seven transcription initiation sites
which we detected are all within a 91 bp region (Fig. 1B). These
major and minor transcription start sites have therefore been
numbered as # 1 - #7. We use the most 5' major start site, #3,
located 109 bp upstream of the translation start codon, as + 1 .
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Fig. 1 . (A) Detection of X5 transcripts initiated at multiple sites RNase protection mapping of RNA from 230-238 cells; non-transfected pane I), mock
transfected (lane II) and transfected with 5',^-globin-E (lane III) The lower part of the gel (Endogenous) shows protected bands corresponding to
endogenous X5 RNA (#1 - #7) and the upper part of the gel (Transfected) shows protected bands ( *MT - #7T) corresponding to X5-globin RNA
The arrows pant to the most 5' major start site #3 (set as +1) protected in endogenous and transfected RNA. RT, read through. (B) The pG5\s-globin
probe. Depicted is the S'^-gtobin-E, transfecton vector including start sites # 1 - #7 with the arrows showing start site #3 (+1). Below is shown
the 503 nucleotide pGS'^-globm probe corresponding to position -140 in the 5 ' ^ promoter and to position +318 in the globin gene. The probe
detects transcription initiation sites used in the endogenous X5 gene and in the transfected S'xs-globin-E^ as shown below for start site #3, i.e. + 1 .
The 5' region of the X5 gene promotes expression of reporter
genes
To test for regulatory elements upstream of the X5 coding
sequence, a 725 bp fragment, 5'^ (Fig. 2A), was cloned
upstream of the CAT reporter gene. A summary of all the
constructs used in this paper is given in Fig. 2. One of the
constructs, 5'^-CAT, was used to look at the promoter activity
of 5'^. Since other promoters, like the Ig promoters, show low
activities in the absence of an enhancer (25-28) we also
constructed 5'X5-CAT-E, which contained the IgH intron
enhancer (E,J, 3' of the CAT gene. In a third construct
(XS'^-CAT-EJ the orientation of the 5',^ fragment was reversed.
Expression of the CAT reporter gene was assayed after trans-
fection into the pre-B cell line 230-238. Figure 3(A) shows one
representative CAT assay. Below each sample the CAT
conversion is shown as percentage (see Methods). 5'xs-CAT
was poorly expressed (1.0%), while the presence of the E,,
enhancer (5' -CAT-E^J increased the expression level 10- to
15-fold. With the XS'^-CAT-E,, construct only background levels
of CAT activity were found (data not shown), showing that there
was no promoter activity when 5'^ was positioned in the
opposite orientation. Similar results were obtained in the 18-81
pre-B cell line (data not shown). We conclude that in the presence
of the E, enhancer the 5',^ fragment, correctly oriented, can
promote transcription in pre-B cells.
To determine whether the 5 '^ promoter initiated transcription
using the same sites as the endogenous X5 gene, the CAT gene
was replaced by a rabbit /3-globin gene (24), to make
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Fig. 2. (A) The 5' region of the X5 gene. The munne Vp,^ , (exon I and
II) and X5 (exon I, II and III) locus and below the 5'region of the X5 gene
used to test for promoter activity, 5'^j (position -613 to +109,
transcription start site +1) is shown. (B) Various reporter gene constructs
of the 5' region of the X5 gene. Several constructs were made based
on the reporter gene CAT without or with an enhancer 3' of CAT either
the SV40 enhancer, denoted Esy, or the IgH intron enhancer, denoted
E.. The 5'^ 5-CAT construct is shown at the top and below is depicted
others with deletions from the 5' end of 5 ' ^ while keeping the 3' end
at +109. The deletion constructs are labelled according to the respective
5' position, i.e. - 272^-CAT starts at position - 272 and + 59^5-CAT
starts at position + 59. Note that the + 59^-CAT vector include the most
3' minor start site while + 90JJ-CAT contains no transcription initiation
site. (C) 5 '^ divided into two regions. Dividing 5 ' ^ into two regions: A ^
(position - 4 5 to +109 containing all transcription initiation sites) and B^
{position - 613 to - 45). (D) Various reporter gene constructs based on
A,-CAT. All constructs are based on the basal A,-CAT construct without
or with the E, enhancer 3' of CAT. A,, the most 3' 150 bp of the Sp€
x promoter including the octamer, TATA box and transcription start site
(see Methods); B^, see (C).
5',^-globin-E,, (Fig. 1B). The 230-238 pre-B cell line was either
mock transfected or transfected with 5',^-globin-E^ and RNA
was prepared to map transcription start sites by RNase protection
(Fig. 1A). Figure 1(B) shows the pGS'^-globin probe and the
predicted protected transcripts initiated at +1 in the endogenous
X5 gene and in the 5'xs-globin-E, transfectant. Seven bands
(# 1 - # 7) corresponding to endogenous X5 transcripts were
detected in mock as well as in 5'xs-globin-E,, transfected cells.
In addition, seven new bands ( # 1 T - #7T) were detected in
5'xs-gtobin-E^ transfected cells. The new transcripts were all 209
nucleotides larger than the respective endogenous transcripts
as expected for transcripts initiated in the 5'^-globin-E,
construct at the same positions as in the endogenous gene. The
intensity of these new bands correlated with the intensity of the
respective bands from the endogenous X5 RNA. We conclude
that the 5',^ region contains the information needed to initiate
transcription similarly to the endogenous gene.
The 5'^ region is developmental regulated
We next asked whether the 5'^ region contained sequence
information sufficient to explain the developmental^ regulated
expression pattern of X5. The IgL x promoter, 5', (1.5 kb, see
Methods), allows expression of a 5',-CAT-E, construct in both
pre-B and mature B cells. Thus, the ratios of 5'^-CAT-E^ and
5',-CAT-E, expression in these cells should show whether 5 '^
confer stage-specific expression. Table 1 shows that none of the
B cell lymphomas (WEHI 279 and K46R) nor normal LPS
stimulated B cells expressed any appreciable level of CAT activity
when driven by the 5\s region, while the control 5',-CAT-E^, was
expressed (although at different levels depending on which cells
were used). In the 230-238 pre-B cells, 5'^-CAT-E, and 5',-
CAT-E, were expressed at similar levels, while in the B cells the
ratio varied between 0.1 and 0.003. Thus, the 5\s activity as
promoter was poor in all B cells tested. We conclude that the
5'xs region functions as a developmental^ regulated promoter
in pre-B cells but not in mature B cells.
Two regions regulating expression of the 5'^-CAT-E^ construct
in pre-B cells
To determine regions important for 5 '^ promoter activity,
constructs with successive deletions in the 5' end of the promoter
were made (Fig. 2B). Since the 5'^ promoter alone conferred
very low activity unless the E, enhancer was provided in the
construct (see results in Fig. 3A) such an enhancer was included
in all promoter-deletion constructs. Figure 3(B) shows one
representative experiment in 230-238 pre-B cells. Actual CAT
conversion levels were similar to earlier experiments, see Fig.
2 and Table 1. Deletions in the 5' end from -613 to -197
showed no major change in CAT activity. At position - 81 the
activity dropped 2-fold and slightly increased at position -45 .
Further 5' deletions showed minor changes. When the last
transcription initiation site was deleted (construct + QOxs-CAT-E^
only background levels of activity were noted. The difference in
expression level between S'^-CAT-E,, and + 90xs-CAT-E)l was
30-fold. We conclude that in the presence of the E,, enhancer,
the 5'^ segment appears to contain several regions which have
different effects on the expression of the reporter gene in pre-B
cells. In order to simplify the interpretation and because of the
results from the following experiments we divided the 5'^
segment into two regions, region A^ (position - 4 5 to +109),
which included all transcription initiation sites, and region B^
(position -613 to -45).
Region B^ shows stage- and tissue-specific suppression of the
basal Ax promoter activity
The activities of the 5'^ deletion constructs (Rg. 2B) were
determined in several non pre-B cell-types by transfections and
CAT assays. Figure 4 shows representative experiments of the
relative CAT activities detected in the K46R B cell line (Fig. 4A),
in the EL-4 T cell line (Rg. 4B) and in 3T3 fibroblasts (Rg. 4C).
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Fig. 3. (A) Transfecton of 230-238 pre-B cells with 5'^-CAT and 5',^-CAT-E,. CAT assay after transient transfectron of the pre-B cell line 230-238
with the 5'^ 5-CAT construct described in Rg. 2(B). The construct named 5'^-CAT-E includes the Ef enhancer 3' of the CAT gene. The activity
is shown below each sample (duplicates) as percentage CAT conversion (see Methoas) (B) CAT activity of 5'-^ deletion constaicts in 230-238 pre-
B cells. The 5\s deletion constructs described in Rg. 2(B), all containing the E, enhancer, were transients transfected into the pre-B cell line 230-238,
followed by CAT assay. The CAT activities were determined and thereafter calculated as relative percentage of 5',-CAT-E, which was set as 100%.
One representative experiment is shown
The constructs contained either the E, enhancer (Fig. 4A and
B) or the Esv enhancer (Fig. 4C).
In the B cell line K46R (Rg. 4A) the relative activity detected
with 5'xs-CAT-E, was low, as described before (see Table 1).
Deletion from the 5' end of 5',^ showed a stepwise increase in
activity up to position -45 , with the 45^5-CAT-E, construct
giving the highest expression level. The relative CAT activity
(50%) with this construct was similar to that found in the pre-B
cell line (see Fig. 3B). Further 5' deletions showed minor changes
until a major drop in expression level with the +90x5-CAT-E
vector, where only background CAT activity was detected. Similar
results were also obtained in the B cell myeloma X63/O (data
not shown).
In the T cell line EL-4 the relative activity detected with
5'xs-CAT-E, was very low. Deletion to position - 6 gave the
highest relative CAT activity (15%). The + 59^-CAT-E,, construct
was active while the + 90XS-CAT-E,, vector was inactive. While
the pattern of expression was similar in EL-4 T cells and K46R
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Table 1 . Relative promoter activity of the 5' regions of the X5 and the IgL, x genes in pre-B and B cells
Cells Actual % CAT conversion in transient transfecton
experiments with"
5'^-CAT-E, (I) 5',-CAT-E,
Relative promoter
activity
(ratio I/I I)
Pre-B cells:
230-238 (Exp. 1)
230-238 (Exp. 2)
8 cells:
WEHI 279 (Exp. 1)
K46R (Exp. 1)
K46R (Exp. 2)
Normal B cells:
spleen, LPS (Exp. 1)
spleen, LPS (Exp. 2)
16.5 ± 1.2
14.8 ± 0.6
0.4
0.8
0.1 ± 0
0.2 ± 0.1
0.1
17.9 ± 1.2
19.5 ± 0.5
5.2 ± 0.4
9.3
10.0 ± 1.0
28.7
31.9
0.9
0.8
0.08
0.09
0.01
0.007
0.003
"Details are given in Methods.
B cells, the relative level of expression in B cells was higher than
that in T cells.
To test the 5' deletion vectors in 3T3 cells, the E,, enhancer
was replaced by the Esv enhancer, since E,, does not function
in 3T3 cells. We compared expression with the 5'^-CAT-Esv
deletion constructs in K46R B cells and 3T3 fibroblasts. In the
B cell line the expression pattern was very similar to that of the
corresponding constructs with the E, enhancer (Fig. 4A). In 3T3
cells the 5'xs-CAT-Esv construct was not expressed (CAT
conversion <1%). The most prominent increase in activity,
10-fold, was detected with both the 81X5-CAT-ESV and
+ 59X6-CAT-ESV constructs. The + PJOXS-CAT-ESV vector showed
no CAT activity. The relative level of CAT activity was higher in
the B cell as compared with that in fibroblasts, however, the
pattern of expression was the same.
The data presented above show that in the presence of a
heterologous enhancer (E, or E^) the 5'^ segment appears to
contain two regions which affect the expression of the reporter
gene in B cells, T cells and fibroblasts. We conclude that, in the
context of a heterologous enhancer, region A^ allows expres-
sion of the reporter gene in all cell types tested (pre-B, B, T and
fibroblasts), suggesting that it acts as a basal promoter. The B^
region suppresses A^ driven expression in B cells, T cells and
in fibroblasts but not in pre-B cells. Thus B^ and E/Esv together
confer pre-B cell-specific expression of the reporter gene CAT.
Bjtf confers pre-B cell stage-specific expression to an IgL x
promoter
The experiments described above showed that B^ and E,
together imposed stage- and tissue-specific expression on
constructs driven off the A^ basal promoter. We wanted to ask
whether these elements could also regulate another promoter
active in both pre-B and B cells. We used a short, 150 bp, IgL
x promoter (here named A,, see Methods) to give an A,-CAT
construct (Fig. 2D). Experiments summarized in Fig. 5 show that
the CAT gene under the control of A, was expressed, provided
the E, enhancer was included (A.-CAT-E,, in both pre-B and B
cells. Inserting B^ upstream of A,(BX5-Ajr-CAT-E)J increased the
activity in B cells 1.5- to 2-fold. However, in the pre-B cells the
activity increased 5-fold above Aj-CAT-E,. Somewhat surpris-
ingly, when E, was removed B^-A^-CAT was still expressed
(25% CAT conversion) in pre-B cells but not in B cells. Even upon
reversing the orientation of Bxs (XB^-A^-CAT) this new construct
was active (7% CAT conversion) in the pre-B cell line. This was
also observed in another pre-B cell line, 18-81 (data not shown).
These experiments show that B^ can act as a stage-specific
enhancer on the heterologous A, promoter. It also shows that
B,^  and E,, together can convey pre-B cell specific expression
to the basal A^ promoter but not to the A, promoter.
Discussion
This study shows that the 5' regulatory region of the pre-B cell-
specific X5 gene (5 ' ^ contains two control regions, A^ and B^,
with strikingly different properties (summarized in Fig. 6). The
Axs region appears to function as a basal promoter in several
cell types (pre-B, B, T cells and fibroblasts). The B^ region, in
contrast, can act in a tissue-specific fashion to suppress
transcription, but can also act in a stage-specific manner to
enhance transcription.
The basal A^ promoter behaves like other TATA-less
promoters in that it initiates transcription at multiple sites. However,
expression depends on an appropriate lineage-related enhancer
(E, for lymphocytes, Esv for fibroblasts).
Region B^ acts dominantly together with a heterologous
enhancer to suppress reporter gene expression driven off its own
promoter in cell types other than pre-B cells. One possibility is
that suppressor factors bind to B^ in non-permissive cells. This
would be consistent with experiments where pre-B cells were
fused with myeloma cells, yielding hybrids in which X5 gene
expression was no longer detectable (3). When region B^ was
introduced upstream of the IgL x promoter, A,, in the presence
of E,, expression in B cells was not suppressed. Surprisingly,
in the absence of E,, B^ could act as an enhancer on the A,
promoter in pre-B cells, but not in B cells, i.e. a pre-B cell stage-
specific enhancer. This suggests that factors present in pre-B
but not B cells bind to B^ and activate transcription from A,.
The different activities obtained with B^ using the two different
promoters could be explained by the fact that A^ is a TATA-less
promoter while A, is a TATA-containing promoter. It has been
shown that such promoters use different components of the basal
machinery to initiate transcription (29,30).
We are interested in identifying the factors which cause the
apparent differences in expression patterns imposed by B^.
Cis-regulatory elements of \5 869
CAT act ivi ty wi th the 5 ' ^ deletion constructs In B cel ls , T cells and f ibroblasts.
A) K46R B cells B) EL-4 T cells
120
100"
1 20"
100-
80-
60
40
2 0 '
I
u | a
^ 5 >* £
O T K <n
•w In «x -
2 » % %
« » in o>
C) K46R B cells and 3T3 fibroblasts
3
20
Fig. 4. CAT activity of 5',^ deletion constructs in B cells, T cells and fibroblasts. The cells were transfected with the 5 ' ^ deletion constructs in Fig.
2(B) containing the E, (A, B) or the Esy enhancer (C) and the relative CAT activities, compared with 5',-CAT-E,, (100%) (A, B) or pSV2-CAT (100%)
(C) were determined. One representative experiment is shown for each cell type. The variation between duplicates within one experiment was s 10<Vb
(A) K46R B cells, (B) EL-4 T cells, (C) 3T3 fibroblasts and K46R B cells as comparison.
Therefore we looked within B^ for sequence recognition motifs
of DNA binding proteins. One DNA binding protein, EBB-1,
present in pre-B and B cells, binds to a motif in the murine
V(yo-Bi promoter and also to a motif in E^ s (31). The EBB-1
protein may be related to Pax-5, which acts on the CD19
promoter (12,32). A protein complex, Lyf-1, detected in lymphoid
cells, binds to the TdT promoter and within B^ (14,33) The
consensus sequence recognized by Lyf-1 is the same as that
of the /iB element present in the E, enhancer (34,35) and that
of a site in the IgL x 3' enhancer (36,37). Several motifs
corresponding to /iE2, /xE4 and the E-box consensus sequence
(38) are present in B^. None of the motifs described above bind
proteins expressed only in pre-B cells or only in non-pre-B cells.
This might indicate that none of these motifs are involved in the
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Fig. 5. Relative CAT activities of A^-CAT based constructs in pre-B and B cells. Transfection of the A.-CAT based constructs described in Fig. 2(D)
into 230-238 pre-B cells (left) and K46R B cells (right). One representative experiment is shown for each cell type. Constructs which include the
E, enhancer are labelled accordingly. B^ is described in Fig. 2(Q. The activity with AX-CAT was in some experiments 1 % and others < 1 % , and
in the experiments shown normalized to 1%. Note that the activity with B^-A^-CAT-E, in the pre-B cell line is out of range (>200%). The activity
with XB^-A.-CAT-E,, in the pre-B cells was 77% and in the B cells it was 20% (not shown). The variation between duplicates within one experiment
was £10%.
CAT activities In preB and B cells with constructs based on different promoters.
A) The basal promoter
Construct preB
15
20
15
B) The basal AK promoter
Construct preB
25
43
234
IS
24
Fig. 6. (A) Constructs based on the basal A ^ promoter and corresponding CAT activities in pre-B and B cells. The transfection vectors contain
the basal A ^ promoter upstream of the CAT reporter gene. The E, enhancer was cloned 3' of the CAT gene. B^ (described in Fig. 2C) was cloned
5' of the Axs promoter. A summary of several independent transfection experiments is shown for 230-238 pre-B cells and K46R B cells. Due to
variations in transfection efficiency between experiments the actual CAT activity with A^-CAT and A,-CAT varied between 0.3 and 1.0%. The data
have been normalized to 1 % for the basal promoter activity obtained. Standard variations within each experiment are < 10% For constructs showing
pre-B cell specific expression the values are written as enlarged numbers. (B) Constructs based on the A, promoter and corresponding CAT activities
in pre-B and B cells. As in (A) except that the A ^ promoter was replaced by the 150 bp IgL x, A,, promoter.
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cell type and differentiation stage-specific regulation of X5 gene
expression. Alternatively, the small differences in reporter gene
expression observed with the 5'^ deletion constructs indicate
that more than one factor could be involved in the pre-B cell-
specific regulation of gene expression, perhaps binding to more
than one motif within B^.
Among the genes differentially expressed during B cell
development TdT, V ^ and X5 show a strikingly similar pattern
of expression. We would therefore expect that future more
detailed analysis of the regulatory elements of these genes would
detect the greatest similarities in TdT and surrogate light chain
genes. In the TdT gene, a basal promoter element active in all
cell typ'es has been described, the so called Inr (9). Furthermore,
elements activating expression in appropriate cell types have
been found in the 5' regions of several genes expressed during
early B cell development, including TdT (14), V ^ B (8), mb-1
(10,11,15) and CD19 (12). So far, there is no element described
that suppresses expression of these genes in non-permissive cell
types. However, other genes like the Ig genes have been
described that are regulated by suppression (39).
To detect 5 \ 5 driven reporter gene expression, a
heterologous enhancer (like EJ had to be provided in our
constructs. Similar observations have been made with other
genes (27,28,37); this suggests that in addition to the 5',^
segment described here another element with an activity similar
to Ef should exist. We are currently searching for such E^-like,
\5-associated, regulatory elements in the neighbourhood of the
X5 gene
So far, we have only used two B-lymphocyte lineage-related
promoters (A^, AJ in our studies of the regulating activities of
B j^ on reporter gene expression. It will be interesting to test the
capacity of other promoters in combination with B,^  (with or
without E^ ) to confer pre-B cell-specific expression of a reporter
gene.
Future experiments will ascertain the pre-B cell-specific
expression pattern conferred by 5\s during normal B cell
development. Constructs containing suitable reporter genes will
be used to generate transgenic mice and stably transfected
normal pre-B-l cells (2). The lineage specific 5\s promoter may
allow us to express a series of genes with functions in B cell
development, differentiation and deregulation at the cellular stage
of the pre-B cell in a transient or permanent way. This should
help us to characterize further the genes and molecules which
influence these lineage specific processes.
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chloramphenicol acetyttransferase
IgH mtron enhancer
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